Inventors list |
Agents list |
Assignees list |
List by place |
Classification tree browser |
Top 100 Inventors |
Top 100 Agents |
Top 100 Assignees |
Anthony W. Czarnik
RENO, NV US
1. 20090215802 DEUTERIUM-ENRICHED LAPATINIB - The present application describes deuterium-enriched lapatinib pharmaceutically acceptable salt forms thereof 08-27-20092. 20090209608 DEUTERIUM-ENRICHED ASENAPINE - The present application describes deuterium-enriched asenapine pharmaceutically acceptable salt forms thereof 08-20-2009
3. 20090156671 DEUTERIUM-ENRICHED OXYBUTYNIN - The present application describes deuterium-enriched oxybutynin pharmaceutically acceptable salt forms thereof 06-18-2009
4. 20090118238 DEUTERIUM-ENRICHED ALENDRONATE - The present application describes deuterium-enriched alendronate sodium pharmaceutically acceptable salt forms thereof 05-07-2009
5. 20090105338 DEUTERIUM-ENRICHED GABEXATE MESYLATE - The present application describes deuterium-enriched gabexate mesylate pharmaceutically acceptable salt forms 04-23-2009
6. 20090088416 DEUTERIUM-ENRICHED LAPAQUISTAT - The present application describes deuterium-enriched lapaquistat pharmaceutically acceptable salt forms thereof 04-02-2009
7. 20090082471 DEUTERIUM-ENRICHED FINGOLIMOD - The present application describes deuterium-enriched fingolimod pharmaceutically acceptable salt forms thereof 03-26-2009
8. 20090082469 DEUTERIUM-ENRICHED TERBINAFINE - The present application describes deuterium-enriched terbinafine pharmaceutically acceptable salt forms thereof 03-26-2009
9. 20090082468 DEUTERIUM-ENRICHED LEVALBUTEROL - The present application describes deuterium-enriched levalbuterol pharmaceutically acceptable salt forms thereof 03-26-2009
10. 20090082465 DEUTERIUM-ENRICHED LISDEXAMFETAMINE - The present application describes deuterium-enriched lisdexamfetamine pharmaceutically acceptable salt forms 03-26-2009
11. 20090082462 DEUTERIUM-ENRICHED ARMODAFINIL - The present application describes deuterium-enriched amodafinil pharmaceutically acceptable salt forms thereof 03-26-2009
12. 20090082461 DEUTERIUM-ENRICHED MODAFINIL - The present application describes deuterium-enriched modafinil pharmaceutically acceptable salt forms thereof 03-26-2009
13. 20090082459 DEUTERIUM-ENRICHED GUANFACINE - The present application describes deuterium-enriched guanfacine pharmaceutically acceptable salt forms thereof 03-26-2009
14. 20090082458 DEUTERIUM-ENRICHED ALISKIREN - The present application describes deuterium-enriched aliskiren pharmaceutically acceptable salt forms thereof 03-26-2009
15. 20090082454 DEUTERIUM-ENRICHED DISUFENTON - The present application describes deuterium-enriched disufenton pharmaceutically acceptable salt forms thereof 03-26-2009
16. 20090082452 DEUTERIUM-ENRICHED LUMIRACOXIB - The present application describes deuterium-enriched lumiracoxib pharmaceutically acceptable salt forms thereof 03-26-2009
17. 20090082450 DEUTERIUM-ENRICHED DICLOFENAC - The present application describes deuterium-enriched diclofenac pharmaceutically acceptable salt forms thereof 03-26-2009
18. 20090082442 DEUTERIUM-ENRICHED LUBIPROSTONE - The present application describes deuterium-enriched lubiprostone pharmaceutically acceptable salt forms thereof 03-26-2009
19. 20090082441 DEUTERIUM-ENRICHED TESAGLITAZAR - The present application describes deuterium-enriched tesaglitazar pharmaceutically acceptable salt forms thereof 03-26-2009
20. 20090082436 DEUTERIUM-ENRICHED RIVASTIGMINE - The present application describes deuterium-enriched rivastigmine pharmaceutically acceptable salt forms thereof 03-26-2009
21. 20090082432 DEUTERIUM-ENRICHED RAMELTEON - The present application describes deuterium-enriched ramelteon pharmaceutically acceptable salt forms thereof 03-26-2009
22. 20090082422 DEUTERIUM-ENRICHED LEVETIRACETAM - The present application describes deuterium-enriched levetiracetam pharmaceutically acceptable salt forms thereof 03-26-2009
23. 20090082420 DEUTERIUM-ENRICHED VILDAGLIPTIN - The present application describes deuterium-enriched vildagliptin pharmaceutically acceptable salt forms thereof 03-26-2009
24. 20090082419 DEUTERIUM-ENRICHED TEGASEROD - The present application describes deuterium-enriched tegaserod pharmaceutically acceptable salt forms thereof 03-26-2009
25. 20090082418 DEUTERIUM-ENRICHED FLUVASTATIN - The present application describes deuterium-enriched fluvastatin pharmaceutically acceptable salt forms thereof 03-26-2009
26. 20090082417 DEUTERIUM-ENRICHED SDX-101 - The present application describes deuterium-enriched SDX-101 pharmaceutically acceptable salt forms thereof 03-26-2009
27. 20090082416 DEUTERIUM-ENRICHED BENDAMUSTINE - The present application describes deuterium-enriched bendamustine pharmaceutically acceptable salt forms thereof 03-26-2009
28. 20090082414 DEUTERIUM-ENRICHED VIRAMIDINE - The present application describes deuterium-enriched viramidine pharmaceutically acceptable salt forms thereof 03-26-2009
29. 20090082413 DEUTERIUM-ENRICHED LETROZOLE - The present application describes deuterium-enriched letrozole pharmaceutically acceptable salt forms thereof 03-26-2009
30. 20090082412 DEUTERIUM-ENRICHED DEFERASIROX - The present application describes deuterium-enriched deferasirox pharmaceutically acceptable salt forms thereof 03-26-2009
31. 20090082405 DEUTERIUM-ENRICHED PIOGLITAZONE - The present application describes deuterium-enriched pioglitazone pharmaceutically acceptable salt forms thereof 03-26-2009
32. 20090082401 DEUTERIUM-ENRICHED TIAGABINE - The present application describes deuterium-enriched tiagabine pharmaceutically acceptable salt forms thereof 03-26-2009
33. 20090082387 DEUTERIUM-ENRICHED NVP-BEZ234 - The present application describes deuterium-enriched NVP-BEZ235 pharmaceutically acceptable salt forms thereof 03-26-2009
34. 20090082385 DEUTERIUM-ENRICHED DESLORATIDINE - The present application describes deuterium-enriched desloratadine pharmaceutically acceptable salt forms thereof 03-26-2009
35. 20090082383 DEUTERIUM-ENRICHED BUPRENORPHINE - The present application describes deuterium-enriched buprenorphine pharmaceutically acceptable salt forms thereof 03-26-2009
36. 20090082382 DEUTERIUM-ENRICHED NALTREXONE - The present application describes deuterium-enriched naltrexone pharmaceutically acceptable salt forms thereof 03-26-2009
37. 20090082380 DEUTERIUM-ENRICHED ROSUVASTATIN - The present application describes deuterium-enriched rosuvastatin pharmaceutically acceptable salt forms thereof 03-26-2009
38. 20090082376 DEUTERIUM-ENRICHED ALOGLIPTIN - The present application describes deuterium-enriched alogliptin pharmaceutically acceptable salt forms thereof 03-26-2009
39. 20090082366 DEUTERIUM-ENRICHED TELAPREVIR - The present application describes deuterium-enriched telaprevir pharmaceutically acceptable salt forms thereof 03-26-2009
40. 20090082364 DEUTERIUM-ENRICHED LEVOCEDTIRIZINE - The present application describes deuterium-enriched levocetirizine pharmaceutically acceptable salt forms thereof 03-26-2009
41. 20090082363 DEUTERIUM-ENRICHED POSACONAZOLE - The present application describes deuterium-enriched posaconazole pharmaceutically acceptable salt forms thereof 03-26-2009
42. 20090082361 DEUTERIUM-ENRICHED IMATINIB - The present application describes deuterium-enriched imatinib pharmaceutically acceptable salt forms thereof 03-26-2009
43. 20090082335 DEUTERIUM-ENRICHED OXCARBAZEPINE - The present application describes deuterium-enriched oxcarbazepine pharmaceutically acceptable salt forms thereof 03-26-2009
44. 20090082334 DEUTERIUM-ENRICHED QUETIAPINE - The present application describes deuterium-enriched quetiapine pharmaceutically acceptable salt forms thereof 03-26-2009
45. 20090082327 DEUTERIUM-ENRICHED MEROPENEM - The present application describes deuterium-enriched meropenem pharmaceutically acceptable salt forms thereof 03-26-2009
46. 20090082323 DEUTERIUM-ENRICHED FULVESTRANT - The present application describes deuterium-enriched fulvestrant pharmaceutically acceptable salt forms thereof 03-26-2009
47. 20090082319 DEUTERIUM-ENRICHED BUDESONIDE - The present application describes deuterium-enriched budesonide pharmaceutically acceptable salt forms thereof 03-26-2009
48. 20090082318 DEUTERIUM-ENRICHED MOMETASONE - The present application describes deuterium-enriched mometasone pharmaceutically acceptable salt forms thereof 03-26-2009
49. 20090082312 DEUTERIUM-ENRICHED ZOLEDRONIC ACID - The present application describes deuterium-enriched zoledronic acid pharmaceutically acceptable salt forms thereof 03-26-2009
50. 20090082306 DEUTERIUM-ENRICHED TELBIVUDINE - The present application describes deuterium-enriched telbivudine pharmaceutically acceptable salt forms thereof 03-26-2009
51. 20090082259 DEUTERIUM-ENRICHED OCTREOTIDE - The present application describes deuterium-enriched octreotide pharmaceutically acceptable salt forms thereof 03-26-2009
52. 20090076264 DEUTERIUM-ENRICHED RIVAROXABAN - The present application describes deuterium-enriched rivaroxaban pharmaceutically acceptable salt forms thereof 03-19-2009
53. 20090076167 DEUTERIUM-ENRICHED TRAMIPROSATE - The present application describes deuterium-enriched tramiprosate pharmaceutically acceptable salt forms thereof 03-19-2009
54. 20090076165 DEUTERIUM-ENRICHED MEMANTINE - The present application describes deuterium-enriched memantine pharmaceutically acceptable salt forms thereof 03-19-2009
55. 20090076164 DEUTERIUM-ENRICHED TAPENTADOL - The present application describes deuterium-enriched tapentadol pharmaceutically acceptable salt forms thereof 03-19-2009
56. 20090076163 DEUTERIUM-ENRICHED DAPOXETINE - The present application describes deuterium-enriched dapoxetine pharmaceutically acceptable salt forms thereof 03-19-2009
57. 20090076162 DEUTERIUM-ENRICHED DESVENLAFAXINE - The present application describes deuterium-enriched desvenlafaxine pharmaceutically acceptable salt forms thereof 03-19-2009
58. 20090076161 DEUTERIUM-ENRICHED BUPROPION - The present application describes deuterium-enriched bupropion pharmaceutically acceptable salt forms thereof 03-19-2009
59. 20090076159 DEUTERIUM-ENRICHED EPLIVANSERIN - The present application describes deuterium-enriched eplivanserin pharmaceutically acceptable salt forms thereof 03-19-2009
60. 20090076157 DEUTERIUM-ENRICHED SENICAPOC - The present application describes deuterium-enriched senicapoc pharmaceutically acceptable salt forms thereof 03-19-2009
61. 20090076154 DEUTERIUM-ENRICHED VORINOSTAT - The present application describes deuterium-enriched vorinostat pharmaceutically acceptable salt forms thereof 03-19-2009
62. 20090076153 DEUTERIUM-ENRICHED TIGECYCLINE - The present application describes deuterium-enriched tigecycline pharmaceutically acceptable salt forms thereof 03-19-2009
63. 20090076150 DEUTERIUM-ENRICHED BROMFENAC - The present application describes deuterium-enriched bromfenac pharmaceutically acceptable salt forms thereof 03-19-2009
64. 20090076148 DEUTERIUM-ENRICHED PRAVASTATIN - The present application describes deuterium-enriched pravastatin pharmaceutically acceptable salt forms thereof 03-19-2009
65. 20090076145 DEUTERIUM-ENRICHED AMIBEGRON - The present application describes deuterium-enriched amibegron pharmaceutically acceptable salt forms thereof 03-19-2009
66. 20090076144 DEUTERIUM-ENRICHED BAZEDOXIFENE - The present application describes deuterium-enriched bazedoxifene pharmaceutically acceptable salt forms thereof 03-19-2009
67. 20090076139 DEUTERIUM-ENRICHED OXALPLATIN - The present application describes deuterium-enriched oxaliplatin pharmaceutically acceptable salt forms thereof 03-19-2009
68. 20090076138 DEUTERIUM-ENRICHED DARUNAVIR - The present application describes deuterium-enriched darunavir pharmaceutically acceptable salt forms thereof 03-19-2009
69. 20090076137 DEUTERIUM-ENRICHED DRONEDARONE - The present application describes deuterium-enriched dronedarone pharmaceutically acceptable salt forms thereof 03-19-2009
70. 20090076135 DEUTERIUM-ENRICHED HYDROMORPHONE - The present application describes deuterium-enriched hydromorphone pharmaceutically acceptable salt forms thereof 03-19-2009
71. 20090076134 DEUTERIUM-ENRICHED SIMVASTATIN - The present application describes deuterium-enriched simvastatin pharmaceutically acceptable salt forms thereof 03-19-2009
72. 20090076133 DEUTERIUM-ENRICHED ZANAMIVIR - The present application describes deuterium-enriched zanamivir pharmaceutically acceptable salt forms thereof 03-19-2009
73. 20090076128 DEUTERIUM-ENRICHED TOPIRAMATE - The present application describes deuterium-enriched topiramate pharmaceutically acceptable salt forms thereof 03-19-2009
74. 20090076127 DEUTERIUM-ENRICHED LAROTAXEL - The present application describes deuterium-enriched larotaxel pharmaceutically acceptable salt forms thereof 03-19-2009
75. 20090076126 DEUTERIUM-ENRICHED ENALAPRIL - The present application describes deuterium-enriched alendronate pharmaceutically acceptable salt forms thereof 03-19-2009
76. 20090076125 DEUTERIUM-ENRICHED GLIMEPIRIDE - The present application describes deuterium-enriched glimepiride pharmaceutically acceptable salt forms thereof 03-19-2009
77. 20090076124 DEUTERIUM-ENRICHED ROPINIROLE - The present application describes deuterium-enriched ropinirole pharmaceutically acceptable salt forms thereof 03-19-2009
78. 20090076121 DEUTERIUM-ENRICHED SUMATRIPTAN - The present application describes deuterium-enriched sumatriptan pharmaceutically acceptable salt forms thereof 03-19-2009
79. 20090076119 DEUTERIUM-ENRICHED RAMIPRIL - The present application describes deuterium-enriched ramipril pharmaceutically acceptable salt forms thereof 03-19-2009
80. 20090076118 DEUTERIUM-ENRICHED SAXAGLIPTIN - The present application describes deuterium-enriched saxagliptin pharmaceutically acceptable salt forms thereof 03-19-2009
81. 20090076117 DEUTERIUM-ENRICHED LAROPIPRANT - The present application describes deuterium-enriched laropiprant pharmaceutically acceptable salt forms thereof 03-19-2009
82. 20090076116 DEUTERIUM-ENRICHED CARVEDIOLO - The present application describes deuterium-enriched carvedilol pharmaceutically acceptable salt forms thereof 03-19-2009
83. 20090076112 DEUTERIUM-ENRICHED ELTROMBOPAG - The present application describes deuterium-enriched eltrombopag pharmaceutically acceptable salt forms thereof 03-19-2009
84. 20090076107 DEUTERIUM-ENRICHED ODANSETRON - The present application describes deuterium-enriched ondansetron pharmaceutically acceptable salt forms thereof 03-19-2009
85. 20090076104 DEUTERIUM-ENRICHED LOSARTAN - The present application describes deuterium-enriched losartan pharmaceutically acceptable salt forms thereof 03-19-2009
86. 20090076102 DEUTERIUM-ENRICHED MURAGLITAZAR - The present application describes deuterium-enriched muraglitazar pharmaceutically acceptable salt forms thereof 03-19-2009
87. 20090076100 DEUTERIUM-ENRICHED GSK625433 - The present application describes deuterium-enriched GSK625433 pharmaceutically acceptable salt forms thereof 03-19-2009
88. 20090076099 DEUTERIUM-ENRICHED IXABEPILONE - The present application describes deuterium-enriched ixabepilone pharmaceutically acceptable salt forms thereof 03-19-2009
89. 20090076097 DEUTERIUM-ENRICHED ATAZANAVIR - The present application describes deuterium-enriched atazanavir pharmaceutically acceptable salt forms thereof 03-19-2009
90. 20090076095 DEUTERIUM-ENRICHED NICORANDIL - The present application describes deuterium-enriched nicorandil pharmaceutically acceptable salt forms thereof 03-19-2009
91. 20090076093 DEUTERIUM-ENRICHED ROSIGLITAZONE - The present application describes deuterium-enriched rosiglitazone pharmaceutically acceptable salt forms thereof 03-19-2009
92. 20090076087 DEUTERIUM-ENRICHED ETORICOXIB - The present application describes deuterium-enriched etoricoxib pharmaceutically acceptable salt forms thereof 03-19-2009
93. 20090076085 DEUTERIUM-ENRICHED NICRAVEN - The present application describes deuterium-enriched nicraven pharmaceutically acceptable salt forms thereof 03-19-2009
94. 20090076083 DEUTERIUM-ENRICHED SAREDUTANT - The present application describes deuterium-enriched saredutant pharmaceutically acceptable salt forms thereof 03-19-2009
95. 20090076082 DEUTERIUM-ENRICHED ALVIMOPAN - The present application describes deuterium-enriched alvimopan pharmaceutically acceptable salt forms thereof 03-19-2009
96. 20090076080 DEUTERIUM-ENRICHED FEXOFENADINE - The present application describes deuterium-enriched fexofenadine pharmaceutically acceptable salt forms thereof 03-19-2009
97. 20090076079 DEUTERIUM-ENRICHED METHYLPHENIDATE - The present application describes deuterium-enriched methylphenidate pharmaceutically acceptable salt forms thereof 03-19-2009
98. 20090076072 DEUTERIUM-ENRICHED TAFENOQUINE - The present application describes deuterium-enriched tafenoquine pharmaceutically acceptable salt forms thereof 03-19-2009
99. 20090076071 DEUTERIUM-ENRICHED RETAPAMULIN - The present application describes deuterium-enriched retapamulin pharmaceutically acceptable salt forms thereof 03-19-2009
100. 20090076069 DEUTERIUM-ENRICHED APIXABAN - The present application describes deuterium-enriched apixaban pharmaceutically acceptable salt forms thereof 03-19-2009
101. 20090076066 DEUTERIUM-ENRICHED ZOLPIDEM - The present application describes deuterium-enriched zolpidem pharmaceutically acceptable salt forms thereof 03-19-2009
102. 20090076065 DEUTERIUM-ENRICHED MK-0812 - The present application describes deuterium-enriched MK-0812 pharmaceutically acceptable salt forms thereof 03-19-2009
103. 20090076060 DEUTERIUM-ENRICHED TEMSIROLIMUS - The present application describes deuterium-enriched temsirolimus pharmaceutically acceptable salt forms thereof 03-19-2009
104. 20090076059 DEUTERIUM-ENRICHED DIANICLINE - The present application describes deuterium-enriched dianicline pharmaceutically acceptable salt forms thereof 03-19-2009
105. 20090076058 DEUTERIUM-ENRICHED FINASTERIDE - The present application describes deuterium-enriched finasteride pharmaceutically acceptable salt forms thereof 03-19-2009
106. 20090076057 DEUTERIUM-ENRICHED DUTASTERIDE - The present application describes deuterium-enriched dutasteride pharmaceutically acceptable salt forms thereof 03-19-2009
107. 20090076056 DEUTERIUM-ENRICHED TOPOTECAN - The present application describes deuterium-enriched topotecan pharmaceutically acceptable salt forms thereof 03-19-2009
108. 20090076055 DEUTERIUM-ENRICHED VINFLUNINE - The present application describes deuterium-enriched vinflunine pharmaceutically acceptable salt forms thereof 03-19-2009
109. 20090076052 DEUTERIUM-ENRICHED NALMEFENE - The present application describes deuterium-enriched nalmefene pharmaceutically acceptable salt forms thereof 03-19-2009
110. 20090076051 DEUTERIUM-ENRICHED METHYLNALTREXONE - The present application describes deuterium-enriched methylnatrexone bromide pharmaceutically acceptable salt 03-19-2009
111. 20090076048 DEUTERIUM-ENRICHED XALIPRODEN - The present application describes deuterium-enriched xaliproden pharmaceutically acceptable salt forms thereof 03-19-2009
112. 20090076042 DEUTERIUM-ENRICHED ERLOTINIB - The present application describes deuterium-enriched erlotinib pharmaceutically acceptable salt forms thereof 03-19-2009
113. 20090076040 DEUTERIUM-ENRICHED VALGANCICLOVIR - The present application describes deuterium-enriched valganciclovir pharmaceutically acceptable salt forms thereof 03-19-2009
114. 20090076039 DEUTERIUM-ENRICHED VALACYCLOVIR - The present application describes deuterium-enriched valacyclovir pharmaceutically acceptable salt forms thereof 03-19-2009
115. 20090076038 DEUTERIUM-ENRICHED ENTECAVIR - The present application describes deuterium-enriched entecavir pharmaceutically acceptable salt forms thereof 03-19-2009
116. 20090076036 DEUTERIUM-ENRICHED RISPERIDONE - The present application describes deuterium-enriched risperidone pharmaceutically acceptable salt forms thereof 03-19-2009
117. 20090076035 DEUTERIUM-ENRICHED PALIPERIDONE - The present application describes deuterium-enriched peliperidone pharmaceutically acceptable salt forms thereof 03-19-2009
118. 20090076034 DEUTERIUM-ENRICHED BMS-690514 - The present application describes deuterium-enriched BMS-690514 pharmaceutically acceptable salt forms thereof 03-19-2009
119. 20090076031 DEUTERIUM-ENRICHED BORTEZOMIB - The present application describes deuterium-enriched bortezomib pharmaceutically acceptable salt forms thereof 03-19-2009
120. 20090076028 DEUTERIUM-ENRICHED ITRACONAZOLE - The present application describes deuterium-enriched itraconazole pharmaceutically acceptable salt forms thereof 03-19-2009
121. 20090076027 DEUTERIUM-ENRICHED LURASIDONE - The present application describes deuterium-enriched lurasidone pharmaceutically acceptable salt forms thereof 03-19-2009
122. 20090076018 DEUTERIUM-ENRICHED RANOLAZINE - The present application describes deuterium-enriched ranolazine pharmaceutically acceptable salt forms thereof 03-19-2009
123. 20090076017 DEUTERIUM-ENRICHED TRABECTEDIN - The present application describes deuterium-enriched trabectedin pharmaceutically acceptable salt forms thereof 03-19-2009
124. 20090076013 DEUTERIUM-ENRICHED SITAGLIPTIN - The present application describes deuterium-enriched sitagliptin pharmaceutically acceptable salt forms thereof 03-19-2009
125. 20090076011 DEUTERIUM-ENRICHED TIRAPAZAMINE - The present application describes deuterium-enriched tirapazamine pharmaceutically acceptable salt forms thereof 03-19-2009
126. 20090076010 DEUTERIUM-ENRICHED LAMOTRIGINE - The present application describes deuterium-enriched lamotrigine pharmaceutically acceptable salt forms thereof 03-19-2009
127. 20090076008 DEUTERIUM-ENRICHED FOSAPREPITANT - The present application describes deuterium-enriched fosaprepitant pharmaceutically acceptable salt forms thereof 03-19-2009
128. 20090076007 DEUTERIUM-ENRICHED APREPITANT - The present application describes deuterium-enriched aprepitant pharmaceutically acceptable salt forms thereof 03-19-2009
129. 20090076000 DEUTERIUM-ENRICHED MYCOPHENOLATE MOFETIL 03-19-2009
130. 20090075997 DEUTERIUM-ENRICHED SATAVAPTAN - The present application describes deuterium-enriched satavaptan pharmaceutically acceptable salt forms thereof 03-19-2009
131. 20090075994 DEUTERIUM-ENRICHED RADAFAXINE - The present application describes deuterium-enriched radafaxine pharmaceutically acceptable salt forms thereof 03-19-2009
132. 20090075991 DEUTERIUM-ENRICHED EFAVIRENZ - The present application describes deuterium-enriched efavirenz pharmaceutically acceptable salt forms thereof 03-19-2009
133. 20090075977 DEUTERIUM-ENRICHED MK0974 - The present application describes deuterium-enriched MK-0974 pharmaceutically acceptable salt forms thereof 03-19-2009
134. 20090075969 DEUTERIUM-ENRICHED DORIPENEM - The present application describes deuterium-enriched doripenem pharmaceutically acceptable salt forms thereof 03-19-2009
135. 20090075967 DEUTERIUM-ENRICHED CEFTRIAXONE - The present application describes deuterium-enriched ceftriaxone pharmaceutically acceptable salt forms thereof 03-19-2009
136. 20090075966 DEUTERIUM-ENRICHED TAZOBACTAM - The present application describes deuterium-enriched tazobactam pharmaceutically acceptable salt forms thereof 03-19-2009
137. 20090075965 DEUTERIUM-ENRICHED AMOXICILIN - The present application describes deuterium-enriched amoxicilin pharmaceutically acceptable salt forms thereof 03-19-2009
138. 20090075959 DEUTERIUM-ENRICHED CICLESONIDE - The present application describes deuterium-enriched ciclesonide pharmaceutically acceptable salt forms thereof 03-19-2009
139. 20090075953 DEUTERIUM-ENRICHED ED-71 - The present application describes deuterium-enriched ED-71 pharmaceutically acceptable salt forms thereof 03-19-2009
140. 20090075947 DEUTERIUM-ENRICHED FOSPROPOFOL - The present application describes deuterium-enriched fospropofol pharmaceutically acceptable salt forms thereof 03-19-2009
141. 20090075944 DEUTERIUM-ENRICHED IBANDRONATE - The present application describes deuterium-enriched ibandronate pharmaceutically acceptable salt forms thereof 03-19-2009
142. 20090075942 DEUTERIUM-ENRICHED FOSAMPRENAVIR - The present application describes deuterium-enriched fosamprenavir pharmaceutically acceptable salt forms thereof 03-19-2009
143. 20090075940 DEUTERIUM-ENRICHED RISEDRONATE - The present application describes deuterium-enriched risedronate pharmaceutically acceptable salt forms thereof 03-19-2009
144. 20090075931 DEUTERIUM-ENRICHED CAPECITABINE - The present application describes deuterium-enriched capecitabine pharmaceutically acceptable salt forms thereof 03-19-2009
145. 20090075930 DEUTERIUM-ENRICHED NELARABINE - The present application describes deuterium-enriched nelarabine pharmaceutically acceptable salt forms thereof 03-19-2009
146. 20090075920 DEUTERIUM-ENRICHED DECITABINE - The present application describes deuterium-enriched decitabine pharmaceutically acceptable salt forms thereof 03-19-2009
147. 20090075917 DEUTERIUM-ENRICHED TELITHROMYCIN - The present application describes deuterium-enriched telithromycin pharmaceutically acceptable salt forms thereof 03-19-2009
148. 20090075914 DEUTERIUM-ENRICHED ODIPARCIL - The present application describes deuterium-enriched odiparcil pharmaceutically acceptable salt forms thereof 03-19-2009
149. 20090075910 DEUTERIUM-ENRICHED FONDAPARINUX - The present application describes deuterium-enriched fondaparinux pharmaceutically acceptable salt forms thereof 03-19-2009
150. 20090075870 DEUTERIUM-ENRICHED CASPOFUNGIN - The present application describes deuterium-enriched caspofungin pharmaceutically acceptable salt forms thereof 03-19-2009
151. 20090069440 DEUTERIUM-ENRICHED ATOMOXETINE - The present application describes deuterium-enriched atomoxetine pharmaceutically acceptable salt forms thereof 03-12-2009
152. 20090069431 DEUTERIUM-ENRICHED MILNACIPRAN - The present application describes deuterium-enriched milnacipran pharmaceutically acceptable salt forms thereof 03-12-2009
153. 20090069415 DEUTERIUM-ENRICHED NEBIVOLOL - The present application describes deuterium-enriched nebivolol pharmaceutically acceptable salt forms thereof 03-12-2009
154. 20090069413 DEUTERIUM-ENRICHED OLOPATADINE - The present application describes deuterium-enriched olopatadine pharmaceutically acceptable salt forms thereof 03-12-2009
155. 20090069412 DEUTERIUM-ENRICHED SUGAMMADEX - The present application describes deuterium-enriched sugammadex pharmaceutically acceptable salt forms thereof 03-12-2009
156. 20090069410 DEUTERIUM-ENRICHED PACLITAXEL - The present application describes deuterium-enriched paclitaxel pharmaceutically acceptable salt forms thereof 03-12-2009
157. 20090069404 DEUTERIUM-ENRICHED VERNAKALANT - The present application describes deuterium-enriched vemakalant pharmaceutically acceptable salt forms thereof 03-12-2009
158. 20090069402 DEUTERIUM-ENRICHED ATRASENTAN - The present application describes deuterium-enriched atrasentan pharmaceutically acceptable salt forms thereof 03-12-2009
159. 20090069399 DEUTERIUM-ENRICHED FROVATRIPTAN - The present application describes deuterium-enriched frovatriptan pharmaceutically acceptable salt forms thereof 03-12-2009
160. 20090069397 DEUTERIUM-ENRICHED OLMESARTAN - The present application describes deuterium-enriched olmesartan pharmaceutically acceptable salt forms thereof 03-12-2009
161. 20090069395 DEUTERIUM-ENRICHED FAMOTIDINE - The present application describes deuterium-enriched famotidine pharmaceutically acceptable salt forms thereof 03-12-2009
162. 20090069390 DEUTERIUM-ENRICHED RUFINAMIDE - The present application describes deuterium-enriched rufinamide pharmaceutically acceptable salt forms thereof 03-12-2009
163. 20090069388 DEUTERIUM-ENRICHED SORAFENIB - The present application describes deuterium-enriched sorafenib pharmaceutically acceptable salt forms thereof 03-12-2009
164. 20090069381 DEUTERIUM-ENRICHED RALOXIFENE - The present application describes deuterium-enriched raloxifene pharmaceutically acceptable salt forms thereof 03-12-2009
165. 20090069380 DEUTERIUM-ENRICHED AROXIFENE - The present application describes deuterium-enriched arzoxifene pharmaceutically acceptable salt forms thereof 03-12-2009
166. 20090069379 DEUTERIUM-ENRICHED LENALIDOMIDE - The present application describes deuterium-enriched lenalidomide pharmaceutically acceptable salt forms thereof 03-12-2009
167. 20090069378 DEUTERIUM-ENRICHED DONEPEZIL - The present application describes deuterium-enriched donepezil pharmaceutically acceptable salt forms thereof 03-12-2009
168. 20090069377 DEUTERIUM-ENRICHED ENZASTAURIN - The present application describes deuterium-enriched enzastaurin pharmaceutically acceptable salt forms thereof 03-12-2009
169. 20090069375 DEUTERIUM-ENRICHED MIGLUSTAT - The present application describes deuterium-enriched miglustat pharmaceutically acceptable salt forms thereof 03-12-2009
170. 20090069369 DEUTERIUM-ENRICHED PRASUGREL - The present application describes deuterium-enriched prasugrel pharmaceutically acceptable salt forms thereof 03-12-2009
171. 20090069366 DEUTERIUM-ENRICHED TACROLIMUS - The present application describes deuterium-enriched tacrolimus pharmaceutically acceptable salt forms thereof 03-12-2009
172. 20090069357 DEUTERIUM-ENRICHED ICLAPRIM - The present application describes deuterium-enriched iclaprim pharmaceutically acceptable salt forms thereof 03-12-2009
173. 20090069354 DEUTERIUM-ENRICHED GEMCITABINE - The present application describes deuterium-enriched gemcitabine pharmaceutically acceptable salt forms thereof 03-12-2009
174. 20090069353 DEUTERIUM-ENRICHED AMBRISENTAN - The present application describes deuterium-enriched ambrisentan pharmaceutically acceptable salt forms thereof 03-12-2009
175. 20090069352 DEUTERIUM-ENRICHED CLAZOSENTAN - The present application describes deuterium-enriched clazosentan pharmaceutically acceptable salt forms thereof 03-12-2009
176. 20090069351 DEUTERIUM-ENRICHED BOSENTAN - The present application describes deuterium-enriched bosentan pharmaceutically acceptable salt forms thereof 03-12-2009
177. 20090069349 DEUTERIUM-ENRICHED PEMETREXED - The present application describes deuterium-enriched pemetrexed pharmaceutically acceptable salt forms thereof 03-12-2009
178. 20090069339 DEUTERIUM-ENRICHED CIPROFLOXACIN - The present application describes deuterium-enriched ciprofloxacin pharmaceutically acceptable salt forms thereof 03-12-2009
179. 20090069295 DEUTERIUM-ENRICHED CONIVAPTAN - The present application describes deuterium-enriched conivaptan pharmaceutically acceptable salt forms thereof 03-12-2009
180. 20090069286 DEUTERIUM-ENRICHED AZTREONAM - The present application describes deuterium-enriched aztreonam pharmaceutically acceptable salt forms thereof 03-12-2009
181. 20090069255 DEUTERIUM-ENRICHED CLARITHROMYCIN - The present application describes deuterium-enriched clarithromycin pharmaceutically acceptable salt forms thereof 03-12-2009
182. 20090069219 DEUTERIUM-ENRICHED TELAVANCIN - The present application describes deuterium-enriched telavancin pharmaceutically acceptable salt forms thereof 03-12-2009
183. 20090062561 DEUTERIUM-ENRICHED LATANOPROST - The present application describes deuterium-enriched latanoprost pharmaceutically acceptable salt forms thereof 03-05-2009
184. 20090062399 DEUTERIUM-ENRICHED SERTRALINE - The present application describes deuterium-enriched sertraline pharmaceutically acceptable salt forms thereof 03-05-2009
185. 20090062398 DEUTERIUM-ENRICHED TOLTERODINE - The present application describes deuterium-enriched tolterodine pharmaceutically acceptable salt forms thereof 03-05-2009
186. 20090062393 DEUTERIUM-ENRICHED PREGABALIN - The present application describes deuterium-enriched pregabalin pharmaceutically acceptable salt forms thereof 03-05-2009
187. 20090062392 DEUTERIUM-ENRICHED GABAPENTIN - The present application describes deuterium-enriched gabapentin pharmaceutically acceptable salt forms thereof 03-05-2009
188. 20090062385 DEUTERIUM-ENRICHED FESOTERODINE - The present application describes deuterium-enriched fesoterodine pharmaceutically acceptable salt forms thereof 03-05-2009
189. 20090062374 DEUTERIUM-ENRICHED LASOFOXIFENE - The present application describes deuterium-enriched lasofoxifene pharmaceutically acceptable salt forms thereof 03-05-2009
190. 20090062373 DEUTERIUM-ENRICHED PF-184298 - The present application describes deuterium-enriched PF-184298 pharmaceutically acceptable salt forms thereof 03-05-2009
191. 20090062368 DEUTERIUM-ENRICHED SUNITINIB - The present application describes deuterium-enriched sunitinib pharmaceutically acceptable salt forms thereof 03-05-2009
192. 20090062367 DEUTERIUM-ENRICHED ELETRIPTAN - The present application describes deuterium-enriched eletriptan pharmaceutically acceptable salt forms thereof 03-05-2009
193. 20090062364 DEUTERIUM-ENRICHED CELECOXIB - The present application describes deuterium-enriched celecoxib pharmaceutically acceptable salt forms thereof 03-05-2009
194. 20090062357 DEUTERIUM-ENRICHED FLUCONAZOLE - The present application describes deuterium-enriched fluconazole pharmaceutically acceptable salt forms thereof 03-05-2009
195. 20090062352 DEUTERIUM-ENRICHED AMLODIPINE - The present application describes deuterium-enriched amlodipine pharmaceutically acceptable salt forms thereof 03-05-2009
196. 20090062347 DEUTERIUM-ENRICHED AXITINIB - The present application describes deuterium-enriched axitinib pharmaceutically acceptable salt forms thereof 03-05-2009
197. 20090062346 DEUTERIUM-ENRICHED TIPRANAVIR - The present application describes deuterium-enriched tipranavir pharmaceutically acceptable salt forms thereof 03-05-2009
198. 20090062331 DEUTERIUM-ENRICHED MARAVIROC - The present application describes deuterium-enriched maraviroc pharmaceutically acceptable salt forms thereof 03-05-2009
199. 20090062325 DEUTERIUM-ENRICHED TIOTROPIUM - The present application describes deuterium-enriched tiotropium pharmaceutically acceptable salt forms thereof 03-05-2009
200. 20090062323 DEUTERIUM-ENRICHED IRINOTECAN - The present application describes deuterium-enriched irinotecan pharmaceutically acceptable salt forms thereof 03-05-2009
201. 20090062316 DEUTERIUM-ENRICHED PELITREXOL - The present application describes deuterium-enriched pelitrexol pharmaceutically acceptable salt forms thereof 03-05-2009
202. 20090062312 DEUTERIUM-ENRICHED INDIPLON - The present application describes deuterium-enriched indiplon pharmaceutically acceptable salt forms thereof 03-05-2009
203. 20090062310 DEUTERIUM-ENRICHED VORICONAZOLE - The present application describes deuterium-enriched voriconazole pharmaceutically acceptable salt forms thereof 03-05-2009
204. 20090062305 DEUTERIUM-ENRICHED CETIRIZINE - The present application describes deuterium-enriched cetirizine pharmaceutically acceptable salt forms thereof 03-05-2009
205. 20090062303 DEUTERIUM-ENRICHED ZIPRASIDONE - The present application describes deuterium-enriched ziprasidone pharmaceutically acceptable salt forms thereof 03-05-2009
206. 20090062300 DEUTERIUM-ENRICHED PRAZOSIN - The present application describes deuterium-enriched prazosin pharmaceutically acceptable salt forms thereof 03-05-2009
207. 20090062299 DEUTERIUM-ENRICHED DOXAZOSIN - The present application describes deuterium-enriched doxazosin pharmaceutically acceptable salt forms thereof 03-05-2009
208. 20090062298 DEUTERIUM-ENRICHED SILDENAFIL - The present application describes deuterium-enriched sildenafil pharmaceutically acceptable salt forms thereof 03-05-2009
209. 20090062283 DEUTERIUM-ENRICHED LINEZOLID - The present application describes deuterium-enriched linezolid pharmaceutically acceptable salt forms thereof 03-05-2009
210. 20090062257 DEUTERIUM-ENRICHED VARENICLINE - The present application describes deuterium-enriched varenicline pharmaceutically acceptable salt forms thereof 03-05-2009
211. 20090062220 DEUTERIUM-ENRICHED AZITHROMYCIN - The present application describes deuterium-enriched azithromycin pharmaceutically acceptable salt forms thereof 03-05-2009
212. 20090062185 DEUTERIUM-ENRICHED ANIDULAFUNGIN - The present application describes deuterium-enriched anidulafungin pharmaceutically acceptable salt forms thereof 03-05-2009
213. 20090062182 DEUTERIUM-ENRICHED DALBAVANCIN - The present application describes deuterium-enriched dalbavancin pharmaceutically acceptable salt forms thereof 03-05-2009
214. 20090005366 DEUTERIUM-ENRICHED OLANZAPINE - The present application describes deuterium-enriched olanzapine pharmaceutically acceptable salt forms thereof 01-01-2009
215. 20080319086 DEUTERIUM-ENRICHED SALMETEROL - The present application describes deuterium-enriched salmeterol pharmaceutically acceptable salt forms thereof 12-25-2008
216. 20080319064 DEUTERIUM-ENRICHED OSELTAMIVIR - The present application describes deuterium-enriched oseltamivir pharmaceutically acceptable salt forms thereof 12-25-2008
217. 20080319007 DEUTERIUM-ENRICHED MONTELUKAST - The present application describes deuterium-enriched montelukast pharmaceutically acceptable salt forms thereof 12-25-2008
218. 20080319004 DEUTERIUM-ENRICHED CLOPIDOGREL - The present application describes deuterium-enriched clopidogrel pharmaceutically acceptable salt forms thereof 12-25-2008
219. 20080318964 DEUTERIUM-ENRICHED ESZOPICLONE - The present application describes deuterium-enriched eszopiclone pharmaceutically acceptable salt forms thereof 12-25-2008
220. 20080318920 DEUTERIUM-ENRICHED EZETIMIBE - The present application describes deuterium-enriched ezetimibe pharmaceutically acceptable salt forms thereof 12-25-2008
221. 20080318915 DEUTERIUM-ENRICHED FLUTICASONE PROPIONATE 12-25-2008
222. 20080318904 DEUTERIUM-ENRICHED TENOFOVIR - The present application describes deuterium-enriched tenofovir pharmaceutically acceptable salt forms thereof 12-25-2008
223. 20080312328 DEUTERIUM-ENRICHED TAMSULOSIN - The present application describes deuterium-enriched tamsulosin pharmaceutically acceptable salt forms thereof 12-18-2008
224. 20080312318 DEUTERIUM-ENRICHED ESCITALOPRAM - The present application describes deuterium-enriched escitalopram pharmaceutically acceptable salt forms thereof 12-18-2008
225. 20080306151 DEUTERIUM-ENRICHED FENOFIBRATE - The present application describes deuterium-enriched fenofibrate pharmaceutically acceptable salt forms thereof 12-11-2008
226. 20080306105 DEUTERIUM-ENRICHED MOXIFLOXACIN - The present application describes deuterium-enriched moxifloxacin pharmaceutically acceptable salt forms thereof 12-11-2008
227. 20080299219 DEUTERIUM-ENRICHED OXYBUTYNIN - The present application describes deuterium-enriched oxybutynin pharmaceutically acceptable salt forms thereof 12-04-2008
228. 20080299218 DEUTERIUM-ENRICHED VALSARTAN - The present application describes deuterium-enriched valsartan pharmaceutically acceptable salt forms thereof 12-04-2008
229. 20080299217 DEUTERIUM-ENRICHED BIFEPRUNOX - The present application describes deuterium-enriched bifeprunox pharmaceutically acceptable salt forms thereof 12-04-2008
230. 20080299216 DEUTERIUM-ENRICHED ARIPIPRAZOLE - The present application describes deuterium-enriched aripiprazole pharmaceutically acceptable salt forms thereof 12-04-2008
231. 20080299215 DEUTERIUM-ENRICHED LESTAURTINIB - The present application describes deuterium-enriched lestaurtinib pharmaceutically acceptable salt forms thereof 12-04-2008
232. 20080280971 DEUTERIUM-ENRICHED ATORVASTATIN - The present application describes deuterium-enriched atorvastatin pharmaceutically acceptable salt forms thereof 11-13-2008